Zen Technologies Limited has announced the grant of 6,000 Employee Stock Options (ESOPs) to its eligible employees under the company's Employee Stock Option Plan 2021. The decision was approved by the Nomination and Remuneration Committee of the Board of Directors during their meeting held on May 01, 2026, as disclosed in the company's regulatory filing to stock exchanges.

ESOP Grant Details

The granted stock options are convertible into an equal number of equity shares with a face value of Re. 1/- each. The grant aligns with the provisions of the SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021.

Pricing and Exercise Terms

The options have been granted at an exercise price of ₹250 per option, which is strategically positioned above the face value of the company's equity shares but below the prevailing market price as of the grant date. This pricing structure provides potential value appreciation for employees while maintaining cost efficiency for the company.

Vesting and Exercise Timeline

The ESOPs follow a structured vesting and exercise schedule designed to retain talent and align employee interests with company performance:

Scheme Administration and Compliance

The Employee Stock Option Plan 2021 is administered and implemented by the Nomination and Remuneration Committee through Zen Technologies Limited Employees Welfare Trust. The grant follows eligibility criteria established under the scheme and ensures compliance with regulatory requirements.

The ESOP grant complies with SEBI regulations and the company has provided comprehensive disclosure details to both NSE and BSE as part of its transparency and compliance obligations. The filing was signed by Company Secretary and Compliance Officer Sourav Dhar, ensuring proper corporate governance procedures were followed.

Zen Technologies has announced a significant leadership appointment with Dr. Sreenivas Rao Yellamanchali joining as Chief Technology Officer effective May 06, 2026. This strategic move brings substantial expertise from the defence research sector to the company's technical leadership team.

Leadership Profile

Dr. Yellamanchali is recognized as an acclaimed scientist with a distinguished career spanning multiple organizations in the defence and technology sectors. His professional journey began at Bharat Heavy Electricals Limited (BHEL), where he gained foundational experience in engineering and technology development.

DRDO Experience

The new CTO brings valuable experience from his tenure at the Defence Research and Development Organisation (DRDO), where he served as Director General of Naval Systems & Materials. This role positioned him at the forefront of naval defence technology development and strategic materials research, providing him with deep insights into advanced defence systems and their applications.

Appointment Details

Strategic Implications

The appointment reflects Zen Technologies' commitment to strengthening its technical capabilities and leadership structure. Dr. Yellamanchali's extensive background in defence research and naval systems development aligns with the company's focus areas and strategic objectives in the technology sector.

This leadership addition is expected to enhance the company's research and development capabilities, particularly in areas related to defence technologies and advanced systems development. His experience spanning both public sector enterprises and defence research organizations brings a comprehensive perspective to the role.